Pancreatic Cancer Research

ResearcherVirginia Commonwealth UniversityActive in the last 2 years

Nicholas Taylor Woods

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4962-9083; OpenAlex author ID A5086801886; NIH RePORTER profile ID 10793813. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
2
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 grants

Papers 2

  1. Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Co-author DOI 10.1016/j.bmcl.2021.128061↗
  2. The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response. Last author DOI 10.1158/1078-0432.ccr-19-1496↗

Grants 2

  1. Targeting subtype specification as a driver of PDAC health disparities R21CA313739↗
  2. United for Health Excellence - Living PDX Program (U4HELPP) U54CA283762↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joshua (Chuck) Harrell · 1 shared grant, 2026 · strength 1.00
  2. Jose Gilberto Trevino · 1 shared grant, 2026 · strength 1.00
  3. Henry C.-H. Law · 2 shared papers, 2020–2021 · strength 0.21
  4. Hannah M. King · 1 shared paper, 2021 · strength 0.12
  5. Amarnath (Amar) Natarajan · 1 shared paper, 2021 · strength 0.12
  6. Thomas C. Caffrey · 1 shared paper, 2020 · strength 0.09
  7. Jean L. Grem · 1 shared paper, 2020 · strength 0.09
  8. Michael Anthony Hollingsworth · 1 shared paper, 2020 · strength 0.09
  9. Paul M. Grandgenett · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.